Coronavirus | SII hopes to launch new COVID-19 vaccine by June

Adar Poonawalla. File   | Photo Credit: Reuters

Serum Institute of India (SII) chief Adar Poonawalla on Saturday said he is hopeful of launching a new COVID-19 vaccine under the brand name Covovax by June. The Institute had earlier applied for clearance to conduct a trial for the vaccine in India.

Covovax is being developed by American company Novavax.

The vaccine was found to be 89.3% effective in a U.K. trial and was nearly as effective in protecting against the U.K. variant. Mr. Poonawalla has said the SII’s partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published “excellent efficacy results”.

Watch | Inside the world's biggest vaccine production hub

Taking to Twitter, Mr. Poonawalla wrote, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!”

Apart from Covovax, four more vaccines are in the pipeline for India.

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Apr 20, 2021 1:39:38 AM |

Next Story